Limited spots remain for the ATN Innovation Summit.
Secure your spot and join 750+ industry executives on June 16 & 17 in NYC.
Bryan Johnson's Blueprint launches a $365-a-year biomarker testing platform, matching Function Health's price as DTC testing heats up.
This week, we break down the recent controversy surrounding Peter Attia's ties to Jeffrey Epstein, and what it could mean for the future of longevity science.
Wellness brands are investing heavily in scientific credibility, but consumer data suggests most people prize price and simplicity more than PhDs and peer-reviewed research.
Bryan Johnson has raised $60 million for Blueprint as celebrity investors back his push to take longevity supplements and anti-aging services mainstream.
Sign Up to Our Newsletter
